• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER 635 VASCULAR SELF-EXPANDING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER 635 VASCULAR SELF-EXPANDING STENT Back to Search Results
Model Number G43841
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/18/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Nio stent, iliac.
 
Event or Problem Description
This patient has had numerous cts and a total of 4 secondary interventions throughout participation in this study.To simplify these cts (as related to this event), please see the table uploaded as an attached file the table provides the date of the imaging, the number of days post-procedure, the maximum aneurysm diameter and presence of an endoleak (as reported by the clinical study site or the core laboratory).Also included is the secondary interventions, the indication for them and the treatments.A ct dated (b)(6) 2021 revealed an enlarging aneurysm.The clinical study site was unable to identify an endoleak and reported the maximum aneurysm diameter was 73mm.The core laboratory evaluation of the ct identified a definite endoleak but the source could not be determined and was listed as an unknown endoleak.A second ct scan dated (b)(6) 2021 was completed.The site again could not identify an endoleak, but continued aneurysm enlargement, now 77mm, led the site to schedule a secondary intervention.Core laboratory evaluation of the ct again revealed an unknown type endoleak.On (b)(6) 2021 (1705 days post-procedure) the patient underwent a secondary intervention to place a proximal aortic cuff extension as well as a left iliac stent graft extension with kissing stents in the left external and internal iliac arteries.Per op-note ¿presumed type 1a and 1b endoleak¿ treated with placement of (36 mm medtronic) proximal aortic cuff extension, distal left iliac stent graft extension (with a 9 x 59 vbx gore stent into the left internal iliac and a 9mm x 79 mm vbx gore stent in the left external iliac artery).The secondary intervention was considered successful.Post procedure angiography revealed the devices were patent with no endoleak or device integrity issues noted.No aortogram was submitted for core laboratory evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER 635 VASCULAR SELF-EXPANDING STENT
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
MDR Report Key11999836
Report Number3005580113-2021-00071
Device Sequence Number4306023
Product Code NIO
UDI-Device Identifier10827002438412
UDI-Public(01)10827002438412(17)190122(10)CR1202156
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/15/2021
Report Date (Section F) 06/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/22/2019
Device Model NumberG43841
Device Catalogue NumberZIV6-35-125-10-40
Device Lot NumberCR1202156
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date05/17/2021
Event Location Hospital
Date Report to Manufacturer06/14/2021
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date06/15/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Weight54
Date Report Sent to FDA06/15/2021
-
-